10 20 30 40 50 60 70 80 1LP6 - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER LYASE 07-MAY-02 1LP6
TITLE CRYSTAL STRUCTURE OF OROTIDINE MONOPHOSPHATE DECARBOXYLASE TITLE 2 COMPLEXED WITH CMP
COMPND MOL_ID: 1; COMPND 2 MOLECULE: OROTIDINE MONOPHOSPHATE DECARBOXYLASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: OMP DECARBOXYLASE, OMPDCASE; COMPND 5 EC: 4.1.1.23; COMPND 6 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ARCHAEA; SOURCE 3 ORGANISM_TAXID: 2157; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 EXPRESSION_SYSTEM_PLASMID: PET15B
KEYWDS TIM BARREL, LYASE
EXPDTA X-RAY DIFFRACTION
AUTHOR N.WU,E.F.PAI
REVDAT 3 24-FEB-09 1LP6 1 VERSN REVDAT 2 01-APR-03 1LP6 1 JRNL REVDAT 1 07-AUG-02 1LP6 0
JRNL AUTH N.WU,E.F.PAI JRNL TITL CRYSTAL STRUCTURES OF INHIBITOR COMPLEXES REVEAL JRNL TITL 2 AN ALTERNATE BINDING MODE IN JRNL TITL 3 OROTIDINE-5'-MONOPHOSPHATE DECARBOXYLASE. JRNL REF J.BIOL.CHEM. V. 277 28080 2002 JRNL REFN ISSN 0021-9258 JRNL PMID 12011084 JRNL DOI 10.1074/JBC.M202362200
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 0.9 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.47 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.8 REMARK 3 NUMBER OF REFLECTIONS : 32255 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.192 REMARK 3 FREE R VALUE : 0.240 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1326 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.02 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.70 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5036 REMARK 3 BIN R VALUE (WORKING SET) : 0.2150 REMARK 3 BIN FREE R VALUE : 0.2710 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 216 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.018 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3195 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 42 REMARK 3 SOLVENT ATOMS : 162 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 14.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 10.18000 REMARK 3 B22 (A**2) : -4.70000 REMARK 3 B33 (A**2) : -5.48000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 3.25000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.26 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.18 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.40 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.95 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.670 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.450 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.700 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.990 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.37 REMARK 3 BSOL : 48.16 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : CMP.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : CMP.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 1LP6 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-MAY-02. REMARK 100 THE RCSB ID CODE IS RCSB016154.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-JUN-01 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 14-BM-C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32661 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.97 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: EPMR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.04 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.09 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: TRISODIUM CITRATE, 1,2,3- REMARK 280 HEPTANETRIOL, 12-CROWN-4, PH 7.5, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 25K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 27.83150 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL UNIT IS A DIMER.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4360 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16750 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -39.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A 1 REMARK 465 ARG A 2 REMARK 465 SER A 3 REMARK 465 ARG A 4 REMARK 465 ARG A 5 REMARK 465 VAL A 6 REMARK 465 ASP A 7 REMARK 465 VAL A 8 REMARK 465 GLY A 181 REMARK 465 VAL A 182 REMARK 465 GLY A 183 REMARK 465 ALA A 184 REMARK 465 GLN A 185 REMARK 465 GLY A 186 REMARK 465 GLY A 187 REMARK 465 ASP A 188 REMARK 465 PRO A 189 REMARK 465 ILE A 222 REMARK 465 LYS A 223 REMARK 465 ASP A 224 REMARK 465 LEU A 225 REMARK 465 LEU A 226 REMARK 465 ILE A 227 REMARK 465 PRO A 228 REMARK 465 GLU A 229 REMARK 465 LEU B 1001 REMARK 465 ARG B 1002 REMARK 465 SER B 1003 REMARK 465 ARG B 1004 REMARK 465 ARG B 1005 REMARK 465 VAL B 1006 REMARK 465 ASP B 1007 REMARK 465 VAL B 1008 REMARK 465 MET B 1009 REMARK 465 ASP B 1010 REMARK 465 VAL B 1182 REMARK 465 GLY B 1183 REMARK 465 ALA B 1184 REMARK 465 GLN B 1185 REMARK 465 GLY B 1186
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 13 14.72 59.69 REMARK 500 ALA A 74 46.57 -145.24 REMARK 500 ASP A 75 -166.12 -114.45 REMARK 500 ARG A 118 -165.45 -118.28 REMARK 500 PHE A 134 -39.99 -130.87 REMARK 500 LEU A 193 0.83 -69.09 REMARK 500 ALA B1074 46.67 -145.99 REMARK 500 PHE B1134 -36.25 -134.31 REMARK 500 ARG B1160 97.28 61.79 REMARK 500 REMARK 500 REMARK: NULL
REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B3157 DISTANCE = 6.02 ANGSTROMS
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE C5P A 2001 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE C5P B 2002
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1LOL RELATED DB: PDB REMARK 900 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE COMPLEXED WITH XMP REMARK 900 RELATED ID: 1LOQ RELATED DB: PDB REMARK 900 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE COMPLEXED WITH UMP REMARK 900 RELATED ID: 1LOR RELATED DB: PDB REMARK 900 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE COMPLEXED WITH BMP REMARK 900 RELATED ID: 1LOS RELATED DB: PDB REMARK 900 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE MUTANT DELTAR203A REMARK 900 COMPLEXED WITH 6-AZAUMP'
REMARK 999 REMARK 999 SEQUENCE REMARK 999 AUTHORS STATE THAT ALTHOUGH RESIDUES 1 AND 1001 ARE MET REMARK 999 AND RESIDUES 101 AND 1101 ARE ARG ACCORDING TO THE REMARK 999 SWISSPROT ENTRY, RESIDUES 1 AND 1001 WERE LEU AND RESIDUES REMARK 999 101 AND 1101 WERE PRO IN THE ORIGINAL CONSTRUCT CLONED REMARK 999 OF MT GENOMIC DNA.
DBREF 1LP6 A 1 228 UNP O26232 PYRF_METTH 1 228 DBREF 1LP6 B 1001 1228 UNP O26232 PYRF_METTH 1 228
SEQADV 1LP6 LEU A 1 UNP O26232 MET 1 SEE REMARK 999 SEQADV 1LP6 PRO A 101 UNP O26232 ARG 101 SEE REMARK 999 SEQADV 1LP6 ILE A 227 UNP O26232 ASN 227 CONFLICT SEQADV 1LP6 GLU A 229 UNP O26232 INSERTION SEQADV 1LP6 LEU B 1001 UNP O26232 MET 1 SEE REMARK 999 SEQADV 1LP6 PRO B 1101 UNP O26232 ARG 101 SEE REMARK 999 SEQADV 1LP6 ILE B 1227 UNP O26232 ASN 227 CONFLICT SEQADV 1LP6 GLU B 1229 UNP O26232 INSERTION
SEQRES 1 A 229 LEU ARG SER ARG ARG VAL ASP VAL MET ASP VAL MET ASN SEQRES 2 A 229 ARG LEU ILE LEU ALA MET ASP LEU MET ASN ARG ASP ASP SEQRES 3 A 229 ALA LEU ARG VAL THR GLY GLU VAL ARG GLU TYR ILE ASP SEQRES 4 A 229 THR VAL LYS ILE GLY TYR PRO LEU VAL LEU SER GLU GLY SEQRES 5 A 229 MET ASP ILE ILE ALA GLU PHE ARG LYS ARG PHE GLY CYS SEQRES 6 A 229 ARG ILE ILE ALA ASP PHE LYS VAL ALA ASP ILE PRO GLU SEQRES 7 A 229 THR ASN GLU LYS ILE CYS ARG ALA THR PHE LYS ALA GLY SEQRES 8 A 229 ALA ASP ALA ILE ILE VAL HIS GLY PHE PRO GLY ALA ASP SEQRES 9 A 229 SER VAL ARG ALA CYS LEU ASN VAL ALA GLU GLU MET GLY SEQRES 10 A 229 ARG GLU VAL PHE LEU LEU THR GLU MET SER HIS PRO GLY SEQRES 11 A 229 ALA GLU MET PHE ILE GLN GLY ALA ALA ASP GLU ILE ALA SEQRES 12 A 229 ARG MET GLY VAL ASP LEU GLY VAL LYS ASN TYR VAL GLY SEQRES 13 A 229 PRO SER THR ARG PRO GLU ARG LEU SER ARG LEU ARG GLU SEQRES 14 A 229 ILE ILE GLY GLN ASP SER PHE LEU ILE SER PRO GLY VAL SEQRES 15 A 229 GLY ALA GLN GLY GLY ASP PRO GLY GLU THR LEU ARG PHE SEQRES 16 A 229 ALA ASP ALA ILE ILE VAL GLY ARG SER ILE TYR LEU ALA SEQRES 17 A 229 ASP ASN PRO ALA ALA ALA ALA ALA GLY ILE ILE GLU SER SEQRES 18 A 229 ILE LYS ASP LEU LEU ILE PRO GLU SEQRES 1 B 229 LEU ARG SER ARG ARG VAL ASP VAL MET ASP VAL MET ASN SEQRES 2 B 229 ARG LEU ILE LEU ALA MET ASP LEU MET ASN ARG ASP ASP SEQRES 3 B 229 ALA LEU ARG VAL THR GLY GLU VAL ARG GLU TYR ILE ASP SEQRES 4 B 229 THR VAL LYS ILE GLY TYR PRO LEU VAL LEU SER GLU GLY SEQRES 5 B 229 MET ASP ILE ILE ALA GLU PHE ARG LYS ARG PHE GLY CYS SEQRES 6 B 229 ARG ILE ILE ALA ASP PHE LYS VAL ALA ASP ILE PRO GLU SEQRES 7 B 229 THR ASN GLU LYS ILE CYS ARG ALA THR PHE LYS ALA GLY SEQRES 8 B 229 ALA ASP ALA ILE ILE VAL HIS GLY PHE PRO GLY ALA ASP SEQRES 9 B 229 SER VAL ARG ALA CYS LEU ASN VAL ALA GLU GLU MET GLY SEQRES 10 B 229 ARG GLU VAL PHE LEU LEU THR GLU MET SER HIS PRO GLY SEQRES 11 B 229 ALA GLU MET PHE ILE GLN GLY ALA ALA ASP GLU ILE ALA SEQRES 12 B 229 ARG MET GLY VAL ASP LEU GLY VAL LYS ASN TYR VAL GLY SEQRES 13 B 229 PRO SER THR ARG PRO GLU ARG LEU SER ARG LEU ARG GLU SEQRES 14 B 229 ILE ILE GLY GLN ASP SER PHE LEU ILE SER PRO GLY VAL SEQRES 15 B 229 GLY ALA GLN GLY GLY ASP PRO GLY GLU THR LEU ARG PHE SEQRES 16 B 229 ALA ASP ALA ILE ILE VAL GLY ARG SER ILE TYR LEU ALA SEQRES 17 B 229 ASP ASN PRO ALA ALA ALA ALA ALA GLY ILE ILE GLU SER SEQRES 18 B 229 ILE LYS ASP LEU LEU ILE PRO GLU
HET C5P A2001 21 HET C5P B2002 21
HETNAM C5P CYTIDINE-5'-MONOPHOSPHATE
FORMUL 3 C5P 2(C9 H14 N3 O8 P) FORMUL 5 HOH *162(H2 O)
HELIX 1 1 VAL A 11 ASN A 13 5 3 HELIX 2 2 ASN A 23 ARG A 35 1 13 HELIX 3 3 TYR A 45 GLY A 52 1 8 HELIX 4 4 ASP A 54 GLY A 64 1 11 HELIX 5 5 ILE A 76 ALA A 90 1 15 HELIX 6 6 GLY A 102 GLY A 117 1 16 HELIX 7 7 PHE A 134 LEU A 149 1 16 HELIX 8 8 ARG A 160 GLY A 172 1 13 HELIX 9 9 GLU A 191 PHE A 195 5 5 HELIX 10 10 GLY A 202 LEU A 207 1 6 HELIX 11 11 ASN A 210 GLU A 220 1 11 HELIX 12 12 VAL B 1011 ASN B 1013 5 3 HELIX 13 13 ASN B 1023 ARG B 1035 1 13 HELIX 14 14 TYR B 1045 GLY B 1052 1 8 HELIX 15 15 MET B 1053 GLY B 1064 1 12 HELIX 16 16 ILE B 1076 ALA B 1090 1 15 HELIX 17 17 GLY B 1102 GLY B 1117 1 16 HELIX 18 18 PHE B 1134 GLY B 1150 1 17 HELIX 19 19 ARG B 1160 GLY B 1172 1 13 HELIX 20 20 PRO B 1189 ARG B 1194 1 6 HELIX 21 21 GLY B 1202 LEU B 1207 1 6 HELIX 22 22 ASN B 1210 LEU B 1226 1 17
SHEET 1 A 9 LEU A 15 MET A 19 0 SHEET 2 A 9 THR A 40 GLY A 44 1 O LYS A 42 N LEU A 17 SHEET 3 A 9 ARG A 66 VAL A 73 1 O ASP A 70 N ILE A 43 SHEET 4 A 9 ALA A 94 HIS A 98 1 O ALA A 94 N ALA A 69 SHEET 5 A 9 GLU A 119 LEU A 123 1 O LEU A 123 N VAL A 97 SHEET 6 A 9 ASN A 153 VAL A 155 1 O ASN A 153 N LEU A 122 SHEET 7 A 9 PHE A 176 SER A 179 1 O PHE A 176 N TYR A 154 SHEET 8 A 9 ALA A 198 VAL A 201 1 O ILE A 200 N SER A 179 SHEET 9 A 9 LEU A 15 MET A 19 1 N ILE A 16 O VAL A 201 SHEET 1 B 9 LEU B1015 ALA B1018 0 SHEET 2 B 9 THR B1040 GLY B1044 1 O LYS B1042 N LEU B1017 SHEET 3 B 9 ARG B1066 VAL B1073 1 O ASP B1070 N ILE B1043 SHEET 4 B 9 ALA B1094 HIS B1098 1 O ALA B1094 N ALA B1069 SHEET 5 B 9 GLU B1119 LEU B1123 1 O LEU B1123 N VAL B1097 SHEET 6 B 9 ASN B1153 VAL B1155 1 O ASN B1153 N LEU B1122 SHEET 7 B 9 PHE B1176 PRO B1180 1 O PHE B1176 N TYR B1154 SHEET 8 B 9 ALA B1198 VAL B1201 1 O ILE B1200 N SER B1179 SHEET 9 B 9 LEU B1015 ALA B1018 1 N ILE B1016 O ILE B1199
CISPEP 1 ASP B 1188 PRO B 1189 0 0.04
SITE 1 AC1 12 ALA A 18 ASP A 20 LYS A 42 SER A 158 SITE 2 AC1 12 PRO A 180 GLY A 202 ARG A 203 HOH A3013 SITE 3 AC1 12 HOH A3015 HOH A3121 HOH A3153 HOH A3162 SITE 1 AC2 15 ALA B1018 ASP B1020 LYS B1042 SER B1158 SITE 2 AC2 15 PRO B1180 GLY B1202 ARG B1203 HOH B3044 SITE 3 AC2 15 HOH B3105 HOH B3116 HOH B3123 HOH B3154 SITE 4 AC2 15 HOH B3156 HOH B3159 HOH B3161
CRYST1 57.130 55.663 65.838 90.00 94.77 90.00 P 1 21 1 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.017504 0.000000 0.001462 0.00000
SCALE2 0.000000 0.017965 0.000000 0.00000
SCALE3 0.000000 0.000000 0.015242 0.00000